Research output per year
Research output per year
Personal profile
Headline
INSTRUCTOR | Medicine, Hematology and Medical Oncology
Biography
Jonathan Anker is a genitourinary medical oncologist, specializing in the care of patients with bladder, renal, prostate, and testicular cancer. His research focuses on optimizing immunotherapy for patients with urothelial cancer through novel therapeutics, biomarker discovery, and elucidating the mechanisms of response and resistance to treatment.
Fingerprint
Dive into the research topics where Jonathan Anker is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Additivity, Not Synergy, Underlies the Efficacy of Current Combination Regimens in Urothelial Cancer
Schlachter, N. M., Miller, E. J., Anker, J. F., Galsky, M. D. & Palmer, A. C., 1 Jun 2026, In: Cancer Research Communications. 6, 6, p. 1447-1454 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A Tumor-Promoting Inflammatory SPP1+ Macrophage–IL6–CRP Axis Drives Immune Dysfunction in Bladder Cancer
Tran, M. A., Cho, B. A., Izadmehr, S., Yoo, S. K., Youssef, D., Anker, J. F., Farkas, A. M., Figueiredo, I., Lee, K., Ananthanarayanan, A., Balan, S., Onkar, S., Banchereau, R., Gupta, S., Chhibber, A., Wang, L., Beaumont, K. G., Li, Z., Garcia-Barros, M. & Bicak, M. & 18 others, , Jun 2026, In: Cancer Discovery. 16, 6, p. 1126-1151 26 p.Research output: Contribution to journal › Article › peer-review
Open Access -
External control arms can validate treatment efficacy in single-arm studies
Miller, E. J., Atiq, S., Anker, J. F. & Tsao, C. K., Jun 2026, In: Journal of the National Cancer Institute. 118, 6, p. 957-958 2 p.Research output: Contribution to journal › Editorial
-
Phase 2 trial of pembrolizumab (P) with response-guided bladder-sparing in patients with muscle-invasive bladder cancer (MIBC; HCRN GU 20-444).
Anker, J. F., King, J., Tripathi, A., Izadmehr, S., Hashemi-Sadraei, N., Pal, S. K., Salous, T., Zhao, Q., Yu, M., Afterman, D., Miller, E. J., Heath, E., Rivera, M., Gure, M., Brody, R., Chan, K. G., Kaimakliotis, H. Z., Mehrazin, R., Sfakianos, J. & Galsky, M. D., Mar 2026, In: Journal of Clinical Oncology. 44, p. 737 1 p.Research output: Contribution to journal › Article › peer-review
-
A Personalized Approach for Oligometastatic Prostate Cancer: Current Understanding and Future Directions
Alerasool, P., Zhou, S., Miller, E., Anker, J., Tsao, B., Kyprianou, N. & Tsao, C. K., Jan 2025, In: Cancers. 17, 1, 147.Research output: Contribution to journal › Review article › peer-review
Open Access4 Scopus citations
Press/Media
-
Breakthrough in Personalized Bladder Cancer Vaccines
Anker, J., Galsky, M. & Bhardwaj, N.
13/05/25
1 item of Media coverage
Press/Media
-
Custom-Made Vaccine Combo Proves Effective in Bladder Cancer
Anker, J., Galsky, M. & Bhardwaj, N.
13/05/25
1 item of Media coverage
Press/Media
-
Study advances understanding of personalised vaccines for bladder cancer
Anker, J., Galsky, M. & Bhardwaj, N.
13/05/25
1 item of Media coverage
Press/Media